Adiponectin

If you were a researcher, how would you answer this question? Adiponectin is a protein hormone produced and secreted exclusively by adipose (fat) tissue. Unlike most adipokines, which increase as fat mass increases, adiponectin levels are inversely correlated with body fat percentage. It is often referred to as the 'fat-burning hormone' because it enhances insulin sensitivity, promotes fatty acid oxidation in the muscles, and inhibits glucose production in the liver. In Russell Clark's clinical framework, low adiponectin is a hallmark of 'metabolic inflexibility.' When a patient has high visceral fat and chronic inflammation, adiponectin production is suppressed, making it incredibly difficult to lose weight even in a caloric deficit. Tirzepatide, through its dual action on GIP and GLP-1 receptors, has been shown to help modulate the hormonal profile of adipose tissue, but the 30-Week Reset goes further by incorporating 'strategic fat loading' and lectin-free living to naturally boost adiponectin expression. Higher levels of adiponectin are protective against the development of Type 2 diabetes and atherosclerosis. In our protocol, we monitor 'non-scale victories' like reduced waist circumference, which often signal an increase in adiponectin levels before the scale shows significant movement. This hormone is vital for maintaining the 'maintenance phase' because it helps keep the metabolic rate high and the body sensitive to its own satiety signals. References: Achari, A. E., & Jain, S. K. (2017). Adiponectin, Inflammation, and the Expression of the Metabolic Syndrome. International Journal of Molecular Sciences, 18(6). Disclaimer: This information is for educational research purposes and does not constitute medical advice.